Clear cell melanoma: A cutaneous clear cell malignancy

Archives of Pathology and Laboratory Medicine

Volumn 138, Issue 10, 2014, Pages 1328-1336

  Pletneva, Maria A ^a   Andea, Aleodor ^a   Palanisamy, Nallasivam ^a   Betz, Bryan L ^a   Carskadon, Shannon ^a   Wang, Min ^a   Patel, Rajiv M ^a   Fullen, Douglas R ^a   Harms, Paul W ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN; CCND1 PROTEIN, HUMAN; CYCLIN D1; DNA BINDING PROTEIN; GLYCOGEN; RREB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

AMINO ACID SUBSTITUTION; CASE REPORT; DIFFERENTIAL DIAGNOSIS; EXTERNAL EAR; GENE DOSAGE; GENETICS; HUMAN; MALE; MELANOMA; METABOLISM; MUTATION; PATHOLOGY; PERIVASCULAR EPITHELIOID CELL NEOPLASMS; SARCOMA, CLEAR CELL; SKIN; SKIN NEOPLASMS; UPREGULATION; VERY ELDERLY;

AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; CYCLIN D1; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; EAR AURICLE; GENE DOSAGE; GLYCOGEN; HUMANS; MALE; MELANOMA; MUTATION; PERIVASCULAR EPITHELIOID CELL NEOPLASMS; PROTO-ONCOGENE PROTEINS B-RAF; SARCOMA, CLEAR CELL; SKIN; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84907662154     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2014-0307-CC     Document Type: Article

References (37)

1. Hocar O, Le Cesne A, Berissi S, et al. Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 52 cases. Dermatol Res Pract. 2012;2012:984096.
2. Patel RM, Downs-Kelly E, Weiss SW, et al. Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma. Mod Pathol. 2005; 18(12):1585-1590.
3. Dim DC, Cooley LD, Miranda RN. Clear cell sarcoma of tendons and aponeuroses: a review. Arch Pathol Lab Med. 2007;131(1):152-156.
4. Morey AL, Murali R, McCarthy SW, et al. Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation. Pathology. 2009;41(4):383-387.
5. Gerami P, Jewell SS, Morrison LE, et al. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol. 2009;33(8):1146-1156.
6. Verdijk RM, Koopmans AE, Kilic E, et al. Histopathologic, immunohistochemical, and cytogenetic analysis of primary clear cell melanoma of the uvea. JAMA Ophthalmol. 2013;131(6):814-816.
7. Mourad WA, Mackay B, Ordonez NG, et al. Clear cell melanoma of the bladder. Ultrastruct Pathol. 1993;17(3-4):463-468.
8. Macak J, Krc I, Elleder M, Lukas Z. Clear cell melanoma of the skin with regressive changes. Histopathology. 1991;18(3):276-277.
9. Furuya M, Shimizu M, Nishihara H, et al. Clear cell variant of malignant melanoma of the uterine cervix: a case report and review of the literature. Gynecol Oncol. 2001;80(3):409-412.
10. Ehara H, Takahashi Y, Saitoh A, et al. Clear cell melanoma of the renal pelvis presenting as a primary tumor. J Urol. 1997;157(2):634.
11. Zelger BG, Debiec-Rychter M, Sciot R, et al. Cytogenetic comparison between clear cell sarcoma and a case of acral clear cell melanoma. J Dtsch Dermatol Ges. 2003;1(5):363-368.
12. Carlson JA, Ross JS, Slominski AJ. New techniques in dermatopathology that help to diagnose and prognosticate melanoma. Clin Dermatol. 2009;27(1): 75-102.
13. Biswas A, Mahalingam M. Cutaneous clear cell neoplasms: a histopathological reappraisal. Am J Dermatopathol. 2012;34(3):237-254.
14. Weedon D. Diagnostic clues. In: Weedon D, ed. Skin Pathology. London, England: Churchill Livingston Elsevier; 2010:27-28.
15. Takeuchi Y, Tamura A, Kamiya M, et al. Immunohistochemical analyses of p63 expression in cutaneous tumours. Br J Dermatol. 2005;153(6):1230-1232.
16. Reis-Filho JS, Torio B, Albergaria A, et al. p63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol. 2002;29(9):517-523.
17. McHugh JB, Hoschar AP, Dvorakova M, et al. p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma. Head Neck Pathol. 2007;1(2):123-131.
18. Ivan D, Hafeez Diwan A, Prieto VG. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin. Mod Pathol. 2005;18(1):137-142.
19. Fujiwara M, Taube J, Sharma M, et al. PAX8 discriminates ovarian metastases from adnexal tumors and other cutaneous metastases. J Cutan Pathol. 2010;37(9):938-943.
20. Lee L, Zhou F, Simms A, et al. Metastatic balloon cell malignant melanoma: a case report and literature review. Int J Clin Exp Pathol. 2011;4(3): 315-321.
21. Kao GF, Helwig EB, Graham JH. Balloon cell malignant melanoma of the skin: a clinicopathologic study of 34 cases with histochemical, immunohistochemical, and ultrastructural observations. Cancer. 1992;69(12):2942-2952.
22. Kazlouskaya V, Guo Y, Maia-Cohen S, et al. Clear-cell melanocytic lesions with balloon-cell and sebocyte-like melanocytes: a unifying concept. Am J Dermatopathol. 2014; 36(5):380-386.
23. Ordonez NG. Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update. Hum Pathol. 2014;45(2):191-205.
24. Guo R, Franco-Palacios M, Russell M, et al. Micropthalmia transcription factor (MITF) as a diagnostic marker for metastatic melanomas negative for other melanoma markers. Int J Clin Exp Pathol. 2013;6(8):1658-1664.
25. Page RN, King R, Mihm MC Jr, et al. Microphthalmia transcription factor and NKI/C3 expression in cellular neurothekeoma. Mod Pathol. 2004;17(2):230- 234.
26. Weedon D. Lentigines, Nevi, and Melanomas. In: Weedon D, ed. Skin Pathology. London, England: Churchill Livingston Elsevier; 2010:709-756.
27. Folpe AL, Mentzel T, Lehr HA, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005;29(12):1558-1575.
28. Ieremia E, Robson A. Cutaneous PEComa: a rare entity to consider in an unusual site. Am J Dermatopathol. 2013. In press.
29. Kiuru M, Hameed M, Busam KJ. Compound clear cell sarcoma misdiagnosed as a Spitz nevus. J Cutan Pathol. 2013;40(11):950-954.
30. Park BM, Jin SA, Choi YD, et al. Two cases of clear cell sarcoma with different clinical and genetic features: cutaneous type with BRAF mutation and subcutaneous type with KIT mutation. Br J Dermatol. 2013;169(6):1346-1352.
31. Walsh SN, Sangueza OP. PEComas: a review with emphasis on cutaneous lesions. Semin Diagn Pathol. 2009;26(3):123-130.
32. Patra S, Vij M, Kota V, et al. Pigmented perivascular epithelioid cell tumor of the liver: report of a rare case with brief review of literature. J Cancer Res Ther. 2013;9(2):305-307.
33. Chang H, Jung W, Kang Y, et al. Pigmented perivascular epithelioid cell tumor (PEComa) of the kidney: a case report and review of the literature. Korean J Pathol. 2012;46(5):499-502.
34. Ferenczi K, Lastra RR, Farkas T, et al. MUM-1 expression differentiates tumors in the PEComa family from clear cell sarcoma and melanoma. Int J Surg Pathol. 2012; 20(1):29-36.
35. Llamas-Velasco M, Mentzel T, Requena L, et al. Cutaneous PEComa does not harbour TFE3 gene fusions: immunohistochemical and molecular study of 17 cases. Histopathology. 2013;63(1):122-129.
36. Tomlins SA, Laxman B, Dhanasekaran SM, et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature. 2007;448(7153):595-599.
37. Qu K, Pan Q, Zhang X, et al. Detection of BRAF V600 mutations in metastatic melanoma: comparison of the Cobas 4800 and Sanger sequencing assays. J Mol Diagn. 2013;15(6):790-795.